Identification of fetal intrauterine growth restriction in pregnancy-induced hypertension women in Saudi Arabia

Abstract

INTRODUCTION: There is evidence that intrauterine growth restriction (IUGR) has negative effects on pregnancy. Placental dysfunction, which limits fetal growth, is intimately related to pregnancy-induced hypertension. This study aims to identify the IUGR in women with pregnancy-induced hypertension.

METHODS: This cross-sectional study, which was done at the Obstetric Department of the Maternity and Children Hospital (MCH) Sakaka, Aljouf, Saudi Arabia, between January 2021 and January 2022, included 162 women with pregnancy-induced hypertension (PIH). Whether nulliparous or multiparous, all of the PIH women were between the ages of 16 and 45. We observed IUGR and outcomes in accordance with the criteria listed in the operational definition. Clinical examinations, patient data files, and ultrasound reports were used to collect the data.

RESULTS: Of these, 105 (64.8%) had fetal detected intrauterine growth restriction, which included low Apgar scores of 19.3%, abortions at 11.4%, low birth weights at 19.3%, preterm births at 20%, and stillbirths at 13.3%. According to our findings, the mean SD values for the population as a whole were 38.95±8.92, 33.73±6.92, 3.00±2.0, 4.91±1.52, 1811±3.32 and 4.21±1.21 for the maternal age, gestational age, duration of disease (weeks), baby weight (grams), and Apgar score, respectively. The relationship of stillbirth in PIH women to maternal age, gestational age, and parity is 89. %, 88.8%,86.6%,72.7% and84.2%,88% and87.6%,85% at considered (p = 0.00), (p = 0.05) and (p=0.00), respectively.

CONCLUSION: The frequency of intrauterine growth restriction (IUGR) in patients with PIH was found to be 64.8%. IUGR is frequently a complication of hypertensive disorders during pregnancy.